中国药学杂志
    
           首页  |  期刊介绍  |  编 委 会  |  投稿指南  |  期刊订阅  |  广告服务  |  会议信息  |  联系我们  | 
�й�ҩѧ��־ 2012, Vol. 47 Issue (10) :776-781    DOI:
����ҩѧר�� ����Ŀ¼ | ����Ŀ¼ | ������� | �߼����� << | >>
����������������̥�������ۺ�����ϵͳ�����о�
���磬���ȣ���С�죬���ţ� ��E*
�Ĵ���ѧ����ҽԺҩ���ƣ��ɶ� 610041
YIN Xi��SU Na�� CHEN Xiao-hong�� TANG Rong��XU Ting*

Download: PDF (1912KB)   HTML (1KB)   Export: BibTeX or EndNote (RIS)      Supporting Info
ժҪ Ŀ�� ���۰���������������̥�������ۺ�������Ч�Ͱ�ȫ�ԡ����� ���������Cochraneͼ��ݡ�PubMed���ݿ⡢Embase���ݿ⡢ISI���ݿ⡢CBM���ݿ⡢CNKI���ݿ⡢VIP���ݿ⡢�����ݿ⣬���백�����ԱȰ�ο��/��������̥�����������������顢ϵͳ���ۣ�SR����Meta��������������������������з���ѧ�������ۺ�Meta�������ο������SR��Meta�������ۡ���� �������������볣�����������̥�����빲����11������������顣��������̥�������ۺ�����Ч�ʲ�����ͳ��ѧ����[RR=1.29��95%CI(1.11�� 1.48)]��P=0.04 �������ʲ���û��ͳ��ѧ����[RR=0.56��95%CI(0.21�� 1.48)]��P=0.73��ʹ������ʱ�������ͳ��ѧ����[MD=-10.71��95%CI(-15.87��-5.55)]��P<0.000 1��סԺʱ�������ͳ��ѧ����[MD=-3.12��95%CI(-4.81��-1.43)]��P<0.000 01��������Ӧ��ADR��������ͳ��ѧ���塣���� ����Ŀǰ֤�ݣ�ʹ�ð���������������̥�������ۺ������������õķα������� ������Ԥ�����䷽����㣬��Ч��ȫ�ɿ���ֵ�����ٴ��ƹ�Ӧ�á�
Service
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
Email Alert
RSS
�����������
����
����
����
����
��E
�ؼ����� ���ᰱ����   ̥�������ۺ���   ������   Meta����     
Abstract��
Keywords��   
�ո�����: 2012-01-17;
���߼��: ���磬Ů������ �о������ٴ�ҩѧ��ѭ֤ҩѧ ��ͨѶ���ߣ���E���У������� �о������ٴ�ҩѧ Tel����028��85422664 E-mail��tingx2009@163.com
���ñ���:   
��С��, ����, ���ŵ� .����������������̥�������ۺ�����ϵͳ�����о�[J]  �й�ҩѧ��־, 2012,V47(10): 776-781
CHEN Xiao-Hong, SU Na, TANG Rong etc .A Systematic Review of Ambroxol Hydrochloride in Patients with Meconium Aspiration Syndrome[J]  Chinese Pharmaceutical Journal, 2012,V47(10): 776-781
��
[1] STRICKLEY R G�� IWATA Q�� WU S�� et al. Pediatric drugs-a review of commercially available oral formulations[J]. J Pharm Sci�� 2007�� 97(5)�� 1731-1774.
[2] FU H�� HUANG C H�� CHEN Q F�� et al. A safety and efficacy observation of mucsolvan to cure neonatal meconium aspiration pneumonia[J]. Mod Med Health���ִ�ҽҩ�������� 2007��23(11)��1643-1644.
[3] HARTUNG H P�� MOUTHON L�� AHMED R�� et al.Clinical applications of intravenous immunoglobulins (IVIg)-beyond immunodeficiencies and neurology[J]. Clin Exp Immunol�� 2009�� 158��suppl 1����23-33.
[4] KE H��LIANG C��TANG Y. Observation of mucosolvan to prevent premature infant hyaline membrane disease[J]. Acta Acad Med Guangzhou������ҽѧԺѧ������2004��32(1)��78-79.
[5] WU S G�� CHEN W B. An application of airway flush of mucosolvan in curing neonatal meconium aspiration syndrome[J]. Int Med Hea Guid������ҽҩ������������2007��13(24)��8-10.
[6] ORANGE J S�� HOSSNY E M�� WEILER C R�� et al. Use of intravenous immunoglobulin in human disease�� a review of evidence by members of the Primary Immunodeficiency Committee of the American academy of allergy�� Asthma and Immunology[J]. J Allergy Clin Immunol�� 2006, 117(4 suppl)��525-553.
[7] MORITA T. Development of deglutition cid jelly for oral administration [J]. Ykugaku Zasshi�� 2003�� 123(8)�� 665-671.
[8] XIONG C L. A therapeutic effect observation of mucosolvan to cure neonatal meconium aspiration syndrome[J]. Zhejiang J Int Tradit Chin West Med���㽭����ҽ�����־���� 2005��15(11)��20-21��
[9] YANG L J��LIU S��LI Y X�� et al. Clinical analysis of mucosolvan to prevent premature infant hyaline membrane disease at early stage[J]. Zhejiang Clin Med J(�㽭�ٴ�ҽѧ)��2005��7(11)��70.
[10] MENNELLA J A�� BEAUCHAMP G K. Optimizing oral medications for children [J]. Clin Ther�� 2008�� 30(11)�� 2120-2132.
[11] ZHANG F L�� YAN Q�� XUE R�� et al. A therapeutic effect observation of large dose mucsolvan to cure neonatal meconium aspiration syndrome[J]. Shandong Med J��ɽ��ҽҩ����2006(19)��59.
[12] PROVAN D�� NOKES TJC�� AGRAWAL S�� et al. IVIG Guideline Development Group of the IVIg Expert Working Group Clinical Guidelines for Immunoglobulin Use[M]. 2nd ed. London�� Department of Health�� 2008.
[13] LIN M X��HUANG Y H��WENG C H��et al. The study on large dose ambroxol hydrochloride combining variant flow rate continuous positive airway by nasal mask to neonatal hyaline membrane disease[J]. Chin Matern Child Health Care���й����ױ�������2007��22(6)��801-803.
[14] SHIMOKAWA K�� ITABASHI T�� YAMAZAKI N�� et al. Survey of administration methods with view to improving compliance in pediatric patients [J]. Jpn J Pharm Health Care Sci�� 2009�� 35(9)�� 662-668.
[15] PAN H X��LIN R H��GUO Y T��et al. Curative effect observation on large dose of ambroxol hydrochloride to treat premature infant hyaline membrane disease[J]. Public Med Forum Mag������ҽѧ��̳����2007��11(9)��799-801.
[16] NATIONAL BLOOD AUTHORITY. Australia.Criteria for the clinical use of intravenous immunoglobulin in Australia[OL]. 2008.http��//www.nba.gov.au/ivig/index.html#/ivig /pdf.
[17] ZENG H W. An analysis on effect of ambroxol in treatment of neonatal meconium aspiration syndrome[J].J Pediatr Pharm������ҩѧ��־���� 2009��15(2)��24-25.
[18] MENNELLA J A�� BEAUCHAMP G K. Optimizing oral medications for children [J]. Clin Ther�� 2008�� 30(11)�� 2120-2132.
[19] HUANG B X��ZHANG S L��XU G P�� et al. Curative effect observation of 40 cases using mucosolvan to prevent premature infant hyaline membrane disease[J]. Mod Med Health���ִ�ҽҩ��������2007��23(6)��814-815.
[20] KAWANO Y�� ITO A�� SASATSU M�� et al. Preparation of orally disintegrating tablets with taste masking fuction�� masking effects in granules prepared with correctives using the dry granulation method and evaluation of tablets prepared using the taste-masking granules [J]. Yakugaku Zasshi�� 2010�� 130(1)�� 81-86.
[21] SHI M F��ZONG X M . Clinical observation of mucosolvan to treat infant hyaline membrane disease[J]. West China Med J������ҽѧ����2007��22��1����137-138.
[22] CHEN X��HUANG T W��XIE K K . Curative effect observation of ncpap combining large dose ambroxol hydrochloride to treat neonatal hyaline membrane disease[J]. Mod Hosp���ִ�ҽԺ����2008��8(05)��29-31.
[23] HONG M��ZHEN H . Experience of 68 cases using large dose of ambroxol to prevent premature infant hyaline membrane disease [J]. Guangxi Med J������ҽѧ����2008��30(4)�� 513-514.
[24] LEONG H��STACHNIK J��BONK M E�� et al. Unlabeled uses of intravenous immune globulin[J]. Am J Health Syst Pharm�� 2008��65(19)��1815-1824.
[25] KAWANO Y�� ITO A�� SASATSU M�� et al. Preparation and evaluation of taste masked orally disintegrating tablets with granules made by the the wet granulation method [J]. Yakugaku Zasshi�� 2010�� 130(12)��1737-1742.
[26] WANG L Z. Ambroxol in the adjuvant therapy of neonatal meconium aspiration syndrome[J]. J Pediatr Pharm������ҩѧ��־���� 2006��12(6)��17-18.
[27] The society of powder technology, Japan/Division of particulate design and preparation. Particulate design and pharmaceutical technology[M]. Tokyo: Jiho. Inc. 2003��239-270.
[28] YUAN X Y��ZHU Y��GAO Y R . Clinical analysis of 43 cases using mucosolvan to prevent premature infant hyaline membrane disease[J]. China Foreign Medical Treatment������ҽ�ƣ���2008��6(15)��103.
[29] FDA.IGIV trials for off-label uses recommended by HHC committee on blood safety [EB/OL]. The Pink Sheet��FDC Report�� 1998�� 60(4)��18.
[30] GARCIA-LLORET M�� MCGHEE S�� CHATILA T A. Immunoglobulin replacement therapy in children[J]. Immunol Allergy Clin North Am�� 2008�� 28(4)��833-849.
[31] GUITAR M��GIARMOLI C��BAEHET P��et al��Ambroxol-induced immune hemolytic anemia[J]��Rew Med Inteme��2006��27��10����797.
[1] �ƿ��£���֮�����£�κ�ǣ����Ӱ�.��������Լ��������˻��������Ӱ��[J]. �й�ҩѧ��־, 2012,22(9): 731-734
[2] ���� �е�Ϊ ������ ������ ���� ������ ¬� .���ᰱ�������й���������־Ը�ߵ�Ⱥ��ҩ��ѧ�о�[J]. �й�ҩѧ��־, 2012,47(3): 218-
[3] ��С�죬���ȣ����ţ����磬��E.������������ҩ������������͸��Ĥ����ϵͳ����[J]. �й�ҩѧ��־, 2012,47(10): 771-776
[4] ��С΢ ��С�� ʯ��ΰ.��ͬ�����������Ԥ��ERCP���������׵����÷�������ȫ������[J]. �й�ҩѧ��־, 2011,46(4): 307-310
[5] ��ΰ.���ᰱ����Ԥ��������������������ۺ������ٴ��۲�[J]. �й�ҩѧ��־, 2008,43(12): 959-960
[6] �����ã�����.��ƿ����������������ߵ�����Ѫ֢����Ч�۲�[J]. �й�ҩѧ��־, 2003,38(S1): 32-33
[7] Ҷ�Գţ�����Ȫ����丣���ݺ���ź磬.��ЧҺ��ɫ�׷��ⶨ���ᰱ��������Ƭ������[J]. �й�ҩѧ��־, 2002,22(10): 592-593
[8] ��Ծ�ģ�����٣����»���Ф������.���ε������Ϲ��������������ߵ�����Ѫ֢53��[J]. �й�ҩѧ��־, 2002,22(10): 609-609
[9] ���ң��Ժ�꣬���ɣ����ϼ�������������ƺͣ�.��������������ǰ�д�������������Ϣ����ķ���[J]. �й�ҩѧ��־, 2002,22(05): 296-297
[10] ��ׯ���������䣬��ҫ������𩣬�ܾ��£�.��Ī����-����ά��ظ����Ƽ������������඾�Ե��ٴ��۲�[J]. �й�ҩѧ��־, 2002,22(04): 223-224
[11] �������������죬���䣬��ȫ�գ��ﻪ����.���ᰱ��������С����Ʊ�������ҩ����[J]. �й�ҩѧ��־, 2002,22(01): 11-13
[12] �ζ�̩ ���� �� ����.��ͬ�������������ҩ��ѧ�о�[J]. �й�ҩѧ��־, 2000,35(06): 399-400
[13] ���䣬��ѧ���������裬�����٣�ʯ�����κ�ܣ���׿��������.�������ᰱ����Ƭ�ڽ��������ڵ������Ч������[J]. �й�ҩѧ��־, 1999,34(08): 541-543
[14] �⽨ѫ�������䣬���壬��־����������.ȥ�����ù������������Ѫ֢��������ҩ������ѧ������Ч[J]. �й�ҩѧ��־, 1999,34(04): 258-260
[15] �ֲʣ��޶������Ļ�.����Ԥ������������ҩ������⿹�����ԱȽ�[J]. �й�ҩѧ��־, 1999,34(02): 111-112
Copyright 2010 by �й�ҩѧ��־